ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,738.52
-1.78%
Dow Jones
42,579.08
0.00%
US Dollar vs MXN
20.2986
0.08%
Brent Oil
70.305
1.39%
Bitcoin
88,928.23
-1.12%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Brasil
  5. BOV

  6. B3 SA - Brasil Bolsa Balcao (B3SA3) Cotización

B3 SA - Brasil Bolsa Balcao

B3 SA - Brasil Bolsa Balcao (B3SA3)

BOV
10.64
0.00
(0.00%)
Cerrado 07 Marzo 2:55PM
Delayed by 15 minutes

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
10.64
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
8.99 Rango de 52 semanas 13.02
Capitalización de Mercado [m]
60.079B
Precio Anterior
10.64
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
47,805,089
Acciones en circulación
5,646,500,000
Rendimiento del Dividendo
2.38%
Ratio Precio/Utilidad
12.99
Beneficio por acción (BPA)
0.81
turnover
9.51B
Beneficio neto
4.58B

Acerca de B3 SA - Brasil Bolsa Balcao

Sector
Security Brokers & Dealers
Industria
Security Brokers & Dealers
Sitio web
www.b3.com.br
Sede
Sao Paulo, Sao Paulo, Bra
Fundado
-
B3 SA - Brasil Bolsa Balcao is listed in the Security Brokers & Dealers sector of the Brazil Bovespa Exchange with ticker B3SA3. The last closing price for B3 SA - Brasil Bolsa Bal... ON was R$10.64. Over the last year, B3 SA - Brasil Bolsa Bal... ON shares have traded in a share price range of R$ 8.99 to R$ 13.02.

B3 SA - Brasil Bolsa Bal... ON currently has 5,646,500,000 shares in issue. The market capitalisation of B3 SA - Brasil Bolsa Bal... ON is R$60.08 billion. B3 SA - Brasil Bolsa Bal... ON has a price to earnings ratio (PE ratio) of 12.99.

B3SA3 Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.020.18832391713710.6210.6910.174818306710.50830342CS
4-0.57-5.0847457627111.2111.7310.174579400611.02197013CS
120.393.8048780487810.2511.739.714780508910.58857174CS
26-1.59-13.000817661512.2312.468.995130949710.58916074CS
52-1.6-13.071895424812.2413.028.994643131910.99341CS
156-3.63-25.4379817814.2716.338.994323522312.13872599CS
260-3.71425633-25.875644440314.3542563323.240700548.993611336912.9945858CS

B3SA3 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de B3 SA - Brasil Bolsa Bal... ON?
El precio actual de las acciones de B3 SA - Brasil Bolsa Bal... ON es R$ 10.64
¿Cuántas acciones de B3 SA - Brasil Bolsa Bal... ON están en circulación?
B3 SA - Brasil Bolsa Bal... ON tiene 5,646,500,000 acciones en circulación
¿Cuál es la capitalización de mercado de B3 SA - Brasil Bolsa Bal... ON?
La capitalización de mercado de B3 SA - Brasil Bolsa Bal... ON es BRL 60.08B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de B3 SA - Brasil Bolsa Bal... ON?
B3 SA - Brasil Bolsa Bal... ON ha negociado en un rango de R$ 8.99 a R$ 13.02 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de B3 SA - Brasil Bolsa Bal... ON?
El ratio precio/beneficio de B3 SA - Brasil Bolsa Bal... ON es 12.99
¿Cuál es el ratio de efectivo a ventas de B3 SA - Brasil Bolsa Bal... ON?
El ratio de efectivo a ventas de B3 SA - Brasil Bolsa Bal... ON es 6.25
¿Cuál es la moneda de reporte de B3 SA - Brasil Bolsa Bal... ON?
B3 SA - Brasil Bolsa Bal... ON presenta sus resultados financieros en BRL
¿Cuál es el último ingresos anual de B3 SA - Brasil Bolsa Bal... ON?
El último ingresos anual de B3 SA - Brasil Bolsa Bal... ON es BRL 9.51B
¿Cuál es el último beneficio anual de B3 SA - Brasil Bolsa Bal... ON?
El último beneficio anual de B3 SA - Brasil Bolsa Bal... ON es BRL 4.58B
¿Cuál es la dirección registrada de B3 SA - Brasil Bolsa Bal... ON?
La dirección registrada de B3 SA - Brasil Bolsa Bal... ON es PRACA ANTONIO PRADO, 48 7 ANDAR, BAIRRO CENTRO, SAO PAULO, SAO PAULO, 01010 901
¿Cuál es la dirección del sitio web de B3 SA - Brasil Bolsa Bal... ON?
La dirección del sitio web de B3 SA - Brasil Bolsa Bal... ON es www.b3.com.br
¿En qué sector industrial opera B3 SA - Brasil Bolsa Bal... ON?
B3 SA - Brasil Bolsa Bal... ON opera en el sector SECURITY BROKERS & DEALERS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ABCB4Banco ABC Brasil S.A.
R$ 19.78
(0.00%)
0
AALR3RAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3QAllianca Saude e Participacoes S.A.
R$ 14.95
(0.00%)
0
AALR3MAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3Allianca Saude e Participacoes S.A.
R$ 12.30
(0.00%)
0
ABCB4Banco ABC Brasil S.A.
R$ 19.78
(0.00%)
0
AALR3RAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3QAllianca Saude e Participacoes S.A.
R$ 14.95
(0.00%)
0
AALR3MAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3Allianca Saude e Participacoes S.A.
R$ 12.30
(0.00%)
0
ABCB4Banco ABC Brasil S.A.
R$ 19.78
(0.00%)
0
AALR3RAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3QAllianca Saude e Participacoes S.A.
R$ 14.95
(0.00%)
0
AALR3MAllianca Saude e Participacoes S.A.
R$ 0.00
(0.00%)
0
AALR3Allianca Saude e Participacoes S.A.
R$ 12.30
(0.00%)
0

Discusión

Ver feed completo
ubueltp ubueltp 2 minutos hace
As Naz is going door to door looking to sell, word is out and valuations become more internally concrete. I expect the share price to increase, as interest and expectations turns into share price increases. GLTL….it’s coming
ELTP
chereb19 chereb19 2 minutos hace
No shares, yet you’re still churning this whiny MK soap opera? ‘Five patients aren’t thriving’? December 2024 says they’re recovering well—metastatic or not, that’s the safety win, not your pity party. ‘Underdosed’ flawing Phase 1? Spare us—FDA’s pre-subs see that India data, Phase 2’s on, safety’s
RDGL
JOoa0ky JOoa0ky 2 minutos hace
Not with Mark Calabria the whale hunter around.
FNMA
KISSINGER KISSINGER 3 minutos hace
This is a fantasy world your living here. Maybe he will merge one of his shitty horses in the shell. Or maybe he chould name one of his foals Bad Vibrations and put it in this POS. A R Merger may get an initial run but it will die fast and it will be a disaster for people buying here except on an in
GVSI
RickNagra RickNagra 3 minutos hace
Calling all whales.
FNMA
Chip79 Chip79 3 minutos hace
StayHumble continues to post the same miss-leading information on a daily basis. The real facts are:

>Kevin Lamb does not work for UBQU, he is a VP at Gentell

>Long term debt has grown fom 1.1M in 2023, to 2.4M in 2024. Overall liabilities jumped from 1.6M to 4.2M
UBQU
StayHumble StayHumble 3 minutos hace
💹Major US Xchange✅$HCWC InfoDeck💹✅💹https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/63599cf2e6708456f8187f4c/1666817273168/HCMC_LDMicroOct2022.pdf
https://investorshub.advfn.com/uimage/uploads/2025/2/23/ijjizHCMC_screenshot_2.png
h
HCWC
gladeshawk gladeshawk 4 minutos hace
QS>>>Fyi on solid state batteries. QS has a chance to be the pick for VW EVs. Just a FYI.

https://www.msn.com/en-us/news/technology/anode-free-solid-state-batteries-could-provide-more-than-500-miles-of-ev-range-on-a-charge/ar-AA1AhRdK?ocid=msedgdhp&pc=DCTS&cvid=821486d608b84aaca1e9c
QS
bucks2pennies bucks2pennies 4 minutos hace
Yes can, GTCH future still a BIG can of worms! Still cannot but feel the mess is unwinding more and more each day. Progress in doing so, IMO, gives more strength to our perspective that GTCH continues to have "REAL" value in addition to their holdings of AVAI and BNIX.

It seems they
AVAI BNIX GTCH
Hoskuld Hoskuld 5 minutos hace
I don't invest that way and I assume other people don't invest that way either. Tesla is a car company. Maybe it wants to be a robot company. The car company is worth $40b. The robot company is worth the other $$850b? I don't think so.
TSLA
Truthsocial Truthsocial 6 minutos hace
FINAL WARNING.....ON RDGL

https://www.nolo.com/legal-encyclopedia/libel-vs-slander-different-types-defamation.html
RDGL
IRON_CROSS IRON_CROSS 6 minutos hace
Long road left to hoe from here, but at least the .07-.09 gaps finally got filled. That's one helluva chart 👇️ ... nasty.

https://investorshub.advfn.com/uimage/uploads/2025/3/7/lkecqScreen_Shot_2025-03-07_at_7.19.56_AM.png

https://investorshub.advfn.com/uimage/
ZOM
StayHumble StayHumble 6 minutos hace
wow💹$DJT launching $100+💹PE Ratio is +475 Facts Matter🇺🇸Maybe
DJT
StayHumble StayHumble 7 minutos hace
💹$HYCM💹on the SILVER screen✅the GoldenGlobe✅💹
HYCM
$7.00 or Nothing $7.00 or Nothing 7 minutos hace
IB_ is a SHE?

Wow - I can't imagine it - sorry - it does not work for me...
ELTP
rodman rodman 8 minutos hace
The race to market is on and the big boy Pfizer cannot bully UEEC!
CelluSTAT Hemostatic Gauze IS the proven hemostasis product.
Gel and foam will need to jump many hurdles and pass many FDA obstacles!

https://clinicaltrials.gov/search?cond=hemostat&viewType=Table&checkSp
UEEC
tulla236a tulla236a 9 minutos hace
are there cracks starting in the dam? if they can tap into finra and the dtcc records too that would destroy those 2.

https://x.com/xMarketNews/status/1897755482753765633
AMC
SC8 SC8 10 minutos hace
Apparently human trial standards are lower in India than USA. FDA was emphatic that effective dosages be worked out before they would authorize human trials. It appears RDGL is still messing with dosages and Indian authorities gave green light to phase 2 anyway.

Again, we know FDA i
RDGL
Roofus Roofus 10 minutos hace
They are compared to if Betaglue had been treating them.
RDGL
$7.00 or Nothing $7.00 or Nothing 10 minutos hace
Making it CLEAR once and for all:
when a company is bought or merges with another company, do all partnerships with financial implication need to be disolved?
Not necessarily! When a company is bought or merges with another, the fate of its financial partnerships depends on several fac
ELTP
work-n-hard work-n-hard 10 minutos hace
MLGO: In https://investorshub.advfn.com/uimage/uploads/2025/3/7/cvtwlScreenshot_2025-03-07_at_07-30-46_MLGO_SharpCharts_StockCharts.com.png
MLGO
europa7 europa7 10 minutos hace
"...usdc on @hedera is live on @cryptocom..."

HBAR Foundation
@HBAR_foundation
Mar 7, 2025
https://x.com/HBAR_foundation/status/1897947502436888594

"...usdc on @hedera is live on @cryptocom..."

https://x.com/cryptocom
*&#x
MSTR
elks elks 11 minutos hace
What y’all say where is a good play at?
stocktowatch stocktowatch 11 minutos hace
$CVM CEL-SCI Reports Fiscal Q1 2025 Financial Results: Multikine Shows Pre-Surgical Tumor Elimination and Regression in Just 3 Weeks
https://finance.yahoo.com/news/cel-sci-reports-fiscal-q1-133000994.html
CVM
KISSINGER KISSINGER 11 minutos hace
ZENADRONE Benefits from Chinese tariffs?? You need to be in business to benefit. ZENA is only in the business of fluff, hype and lies.

This POS is going to buite it hard just like EPAZD and all the other PASSLEY deals before it. Arent you embarassed Shaun?? Probably not since you hav
EPAZD

Su Consulta Reciente

BOV
B3SA3
B3 SA - Brasil Bolsa Bal... ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados

Quitar anuncios

Suscríbete a una experiencia sin publicidad

Sin anuncios

Pruébalo ahora

Mantenga los anuncios